Vitality Watch

Dossier pubmed preclinical 23-sep-2026
Animal model, organoid, or cell-culture result — not yet human

Engineered Extracellular Vesicle Revitalizing Macrophage Energy Metabolism for Aged Wound Repair.

Key claim: 4-Octyl itaconate–engineered extracellular vesicles restore macrophage arginine–oxidative phosphorylation metabolism via ASS1, reverse mitochondrial dysfunction and senescence, and accelerate aged and diabetic skin wound repair in mice.

Abstract

One major obstacle for aged wound healing is the abnormal senescence of macrophages in chronic wounds which causes immunosenescence. Tissue homeostasis depends on regulation of metabolism in accumulating senescent cells (SnCs) with aging, and cell activation for aged tissue repair requires sufficient energy. Therapeutic advancements are potential by employing metabolic strategies for intervention. First, a disorder of arginine-oxidative phosphorylation metabolism in aging skin was found, which may be the main culprit of aging. Engineered EVs (4-octyl itaconate (4OI)-EVs) which possess naturally abundance of mitochondrial proteins have been developed here. Our findings demonstrate that 4OI-engineered EV (4OI-EV) may accelerate the repair of aged mouse skin and diabetic mouse skin, reduce cellular senescence, and recover cell dysfunctions. After 4OI-EV therapy, metabolism has been notably altered, with decreased glycolysis and increased arginine-oxidative phosphorylation axis through enhanced argininosuccinate synthetase 1 (ASS1) level. We demonstrate how 4OI-EV partially restores macrophages senescence by reversing mitochondrial dysfunctions and mitophagy suppressions via ASS1 which may be identified as a potential effective target for alleviating skin aging.

Why this matters

Engineered EVs are a fast-moving preclinical trend often marketed alongside exosome therapies already sold in wellness clinics, so a mechanistically specific mouse result — metabolic reprogramming of senescent macrophages via 4OI cargo — is the kind of finding that will be cited to legitimize consumer offerings well ahead of any human data. Logging it keeps the trend/evidence gap visible: the mechanism is concrete and novel, but the readout is aged and diabetic mouse wounds, not people.

Source

Link

Briefing card

Engineered Extracellular Vesicle Revitalizing Macrophage Energy Metabolism for Aged Wound Repair.
Stage: preclinical · pubmed · 23-sep-2026

Applies to preclinical wound-healing and senescence-reversal research; no human wound or diabetic ulcer readout yet.

4-Octyl itaconate–engineered extracellular vesicles restore macrophage arginine–oxidative phosphorylation metabolism via ASS1, reverse mitochondrial dysfunction and senescence, and accelerate aged and diabetic skin wound repair in mice.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1002/adma.75099

build build 880 · 2bcef25 · 2026-11-18